IN 1922 the late Dr. Canti and I were interested in the problem of how radium brought about the destruction of cancer cells in carcinoma of the cervix. -We cut oections before and after treatment and discovered some obvious changes [1], but did not get very far in the solution of the problem. At that time, the late Dr. Strangeways was doing some of the earliest quantitative work on the biological effects produced by X-ray. He used fibroblasts in tissue culture. We then joined forces [4] and Strangeways and his collaborators did some pioneer work on the subject [21. This type of work has continued at the Strangeways Research Laboratories ever since, and recently Dr. Spear and Dr. Glucksmann started their systematic work oil the effects of irradiation on tissue in vivo and have-now shown that similar quantitative methods are applicable to growth under these conditions.
I do not propose to trace all the stages of their investigations which eventually brought them to their work on human malignant tumours [3, 5] .
In treating carcinoma of the cervix by radiotherapy for many years, certain puzzling questions arose, why, for exaniple, among Stage 1 cases should.,only 50% do well and the other 50% do badly? Again, the majoritv of advanced cases ended fatally within a few months and tlie growth did not clear up even dlose to the radium applicator, although it.was obvious that the malignant cells locally got as much irradiation as the cells in the early and successfully treated cases. It is also true that occasionally an advanced case which had been given a small dose, possibly as a placebo, cleared up and lived for years.
It was easy to say that solme growths are more radio-sensitive than others, but that did not help to advance the subject. I think it is fair to say that Spear and Gliicksmann are the first to throw any real light on this very important subject of radio-sensitivity.
The first point that they have proved is that with the "Stockholm Technique" and its modifications the most "radio-curable" are the well-differentiated growths and not the undifferentiated growths. I use the word radio-curable to mean the disappearance of carcinoma cells in sectlons taken after treatment. This came as a surprise to some of us who had observed large -hypertrophic growths (which were assumed to be undifferentiated) disappear macroscopically in a few wpeks. Some of these tumours in fact are differentiated, some undifferentiated, and it has now been found that it is the anaplastic type of growth which on section more frequently shows a persistence of viable malignant cells after irradiation.
It is important to be quite clear as to what we mean by the terms Differentiated and Undifferentiated growths. In "Differentiated" growths, which we will call Anaplastic Squamous (AS), the cells when young resemble normal basal cells, but when growing old they either undergo normal keratinization giving rise to typical cell nests or they undergo abnormal keratinization giving rise to an aggregation of basal cells round a necrotic core ( fig. 1) .
In "Undifferentiated" tumours called Anaplastic Parakeratotic (AP), the cells when young are capable of active mitosis, but degenerate as they get older by a process of cytoplasmic condensation (parakeratosis) or by nuclear disintegration (fig. 2 ).
If a large number of differentiated and undifferentiated tumours are classified accora ing to the stage of the disease, when first seen it will be found that the differentiated tumours predominate in the early stages, and the undifferentiated tumours in the late stages. M =mitotic cell. Shows some young undifferentiated cells with small amount of cytoplasm, darkly stained nuclei, qnd absence of distinct cell wall. The section also contains some more mature cells which show differentiation and the nuclei are paler, the cytoplasm is cosinophilic and there is a clearly defined cell wall. differentiated growth. If this were so, it would be expected that there would be a longer history in undifferentiated growths than in differentiated growths in the same stage. It is impossible t'o get an accurate history of duration of the disease, but judging from the length of time irregular bleeding has continued there is no evidence of any difference in the average duration of symptoms between the two types of tumour in the same stage though a few growths give quite long histories. It is also interesting to note that the average history of Stage 1 and Stage 4 is 4-2 months and 7-5 months respectively. It seems, therefore, that a tumour staged as 4 is more often one which has grown quickly than one which has been slowly, growing for a long time, but it still remains to be explained why a quickly growing tumour does not give rise to symptoms in the early stages and thus attract attention.
Glucksmann has studied pre-radiation sections of 346 tumours in which a five-years' follow-up was possible, and found that of the 87 differentiated tumours 28 patients lived for five years or more = 32%, but of the 259 undifferentiated tumours only 40 lived for five years = 15%. 
Mitotic cells
There are only minor variations in the cell counts throughout the period of observation. Death occurred at month 7. Clinically this was considered at first unfavourable, then as doing well, but finally as unfavourable.
Section of Obstetrics and Gyncecology The table shows quite clearly that tumours of the AP type respond less well to radiation treatment (by the technique here used) than those of the AS type, the difference being most marked in clinical Stage 3, where the proportion of patients with AS tumours who survive five years is more than twice the corresponding figure for patients with AP tumours.
At first sight it might be thought that the greater number of well-differentiated tumours in Stages I and 2 would account for the better results in well-differentiated tumours, but a glance at Table II shows that in the same stage the well-differentiated do better than the undifferentiated. Further it might be thought that the patients with AP tumours in Stage 3 did'ijadly because these growths had already given rise to metastases. This may be true in some cases but the fact that sections taken from the primary growth after treatment still show growth to be present, and that the recurrence occurs within the irradiated area proves that there must be a difference in the reaction of these tumours to irradiation compared with the AS tumours.
In addition to being able to §tate whether a tumour is likely to be "radio-curable" (i.e. that the tumour is not likely to recur in the treated area) by a study of the pre-radiation biopsy, Gliicksmann has worked out a method wherebv it is possible to make a more accurate prognosis of the final results of the treatment on the local growth in any given case. This is done by a quantitative study of post-radiation sections for comparison with the pre-radiation section. This method has been worked out on sections taken from many institutions, and among these is Mount Vernon Hospital. I send sections to Dr. Glucksmann at Cambridge who works out the prognosis, and I go up about once a quarter with the clinical notes of the case to compare the results.
The following is the method by which the tumour response is judged. Sections are always taken from the growing edge of the tumour. This is an important point, as, if sections are taken from the centre of the growth, the cells may be too necrotic to give results of any value. I may add that Dr. Glucksmann has taken many sections fronj the growing edge of different parts of the same tumour, where a cancer has been excised, and the slides have shown the same picture in each selected portion of the tumour.
Having obtained a pre-radiation section. percentage counts are made of the following four types of cells: Biopsies are then taken on at least two occasions after the treatment has begun and the percentage counts made in the same way. All the counts are then plotted on a graph against time on a convenient scale. Two series of micrographs will illustrate the method in practice. The first series shows histological appearance of serial biopsies from an unsuccessfully treated tumour (figs. 4, 5, 6, 7). Fig. 8 shows a quantitative histological chart made from counts in the above examples.
The second series illustrates a successfully irradiated tumour (figs. 9, 10, 11, 12). Fig. 13 shows a quantitative histological chart made from counts in figs. 9-12. It is now necessary to see how the prognosis given by the histologist xx ithin three weeks of the treatment, and which depends on the reaction of the primary growth as revealed by these cell counts, agrees with the prognosis given by the clinician who sees the patient from time to time in the "follow-up". In many cases the clinician is too optimistic in the early months, as he sees the growth disappear macroscopically, but after two years the difference between the two prognoses has disappeared in most cases as will be seen in Table III . 14T * The histological evaluation is made within three weeks of beginning treatment.
t Includes 9 patients known to have had insufficient treatment in affected regions at a distance from the biopsy site.
t Among the " 14 no reports " for " over 2 years " column are a number of patients not yet two years from treatment.
If, as I believe, this method is of value in giving a prognosis, then we should be able to use such curves in judging between the effect of different techniques without waiting for five years in order to compare the results of such methods of treatment. Realizing that the undifferentiated cases do badly, I decided to try a modified technique, and have now as a beginning treated 38 cases using the same amount of radium, the same number of hours, but a continuous dose instead of interrupted applications. It is too early to make any statement as to the clinical results but the histological picture suggests a definite improvement.
So far I have tried to point out the importance of the histology in making a prognosis in case of carcinoma of the cervix treated by irradiation, and the value of such observations in planning new techniques. This does not explain all our failures, there are many other factors which must be investigated aind one important factor is the distribution of the irradiation. The ideal to be aimed at is an equal distribution of irradiation over the whole area affected by the growth. Dr. Neary has studied this problem very carefully and in 1943 published a paper in the British Journal of Radiology, i6, 225-233, and has constructed an applicator embodying these ideas. AIn applicator embodying some of these principles has also been designed by Mr. Blomfield with the vaginal radium in the middle line. I do not think that his design will give a good distribution of the radiation although it will be more adaptable to different-sized vagirie. Dr. G. J. Neary stated that he had shown in his paper that the radium in the uterus should be concentrated as far as possible near the fundus and that the radium in the vagina should be plac.ed at the mid-line. Further, the amount of this vaginal radium should be very considerably increased in order to produce -an appreciable improvement in the dose at the more outlying region of spread of the disease in the pelvis. The increased amount of radium in the vagina necessitates the use of heavy absorbing screens of platinum or similar metals in order to protect structures such as the rectum from excessive irradiation.
An applicator embodying these principles has now been constructed (with the aid of a grant from the Medical Research Council) to Dr. Neary's design and the work was executed by Mr. Powell and Mr. Aldridge of Messrs. Johnson, Matthey & Co. Ltd. It must be emphasized that there is a wide latitude in the actual design decided on. The applilcator referred to here is only one possible version and is intended as an experiment and, if successful, a range of applicators of different sizes will be used. It is in three sections; the uterine tube of adjustable length contains 70 mg. of radium and is inserted first. Next the upper half of the vaginal portion is inserted, followed by the lower half. The whole system is then simply locked together whereupon the vaginal radium consisting of two sources of 140 mg. each is inserted. The total treatment time is to be about 72 hours. The transverse diameter of the vaginal portion of the applicator is 4 cm., the anteroposterior diameter 31 cm. The diameter of the uterine tube is 7 mm., the length may be adjusted between 3-3 and 5-3 cm.
The dose around the internal os and parametria is 7,000 to 8,000 r (fig. 1) . The maximum dose at the pelvic wall ( fig. 1) is 5,400 r while the average dose over a 5 cm. length of the pelvic wall around B is 4,700 r. The average dose to the posterior vaginal wall is about 4,500 r (rectum, not more than 4,000 r). Figs. 1 and 2 show a comparison of the dosage with that in the average Marie Curie technique, deduced from the data of Mayneord and Honeybourne (American Journal Roentgenology and Radium Therapy, 45, [235] [236] [237] [238] [239] [240] [241] [242] [243] [244] [245] [246] [247] [248] [249] 1941) . This shows a transverse section across the pelvis at the level of the internal os. The very, much improved lateral extension of the radiation field of the new applicator is clear, the pelvic wall dose being 5,400 r instead of 2,000 r in the Marie Curie technique. The applicator is fixed and supported in position by a strong harness attached by straps and belt to the patient. (Brit. J. Radiol., 1943, 16, 225.) Mr. Anthony Green: In certain cases of carcinoma of the cervix the main point is the increased dose obtained in the outer part of the broad ligament, and Neary's appliance is an important advance. The disadvantages of the applicator would appear to be first, that 70 mg. of radium is concentrated against a very small section of the interior of the uterus, thus raising the dosage in r units to a level much greater than has ever been done before. It is possible that this -may be dangerous, and produce local uterine radionecrosis. Only the results can show whether this is produced' or not. A second disadvantage is that the applicator may not be useful for all types of carcinoma of the cervix. The large fungating carcinoma of the cervix, filling a large proportion of the vault and the contracting eroding type of carcinoma or a small vagina may not permit the applicator to be used. Despite the increased range of the radium, there is still a limit to its efficacy in terms of distance from the mid-line. and although early Group 2 cases will undoubtedly be more effectively treated if they are suitable, extension well out toward the pelvic wall will still need supplementary treatment by X-ray therapy to raise the dosage to the required level.
It is not in the best interest of the patient to standardize a technique ,for all kinds of growth, having in mind the fact that they vary considerably, from the stenosing contracting type to the large cauliflower mass, and there is a variable extension of growth into the broad ligament on one or other side or both. It is clear that a mass in the broad ligament of large dimensions or near the lateral nelvic wall is beyond the effective range of radium however skilfully it is applied, and whatever intra-uterine and intravaginal apparatus may be used. The possible exception to this is a highly radio-sensitive growth, which. however, is found in the minority of cases.
Principles of treatment.-It is better to use a moderate dose of X-rays to shrink down a large growth to such a size that it brings it within the effective range of the radium, and secondly it is an obvious advantage to shrink down the primary growth if it is bleeding profusely, and causing a foul filthy condition of the vaginal vault.
A disadvantage of preliminary X-rays is that in a few cases the os is inclined to scar, and it is difficult to introduce the radium, but this can be readily overcome: The cervical lumen can be maintained artificially and more than four weeks' interval between X-rays and radium should be avoided. On the other hand, one has to balance the advantage that the os is more readily located when certain filthy bleeding growths are shrunken down and consequently the lumen is more visible. It has-been claimed by some that even the large growths do shrink considerably after the first and second radium treatment thus: bringing the outer part of the growth within the range of the radium for its second or third application. This is a misleading statement because it is clear that the outer part of the growth as it shrinks has only received its contribution of dose close to the radium, possibly on the third application only. and is uneoually dosed.
With regard to the application of radium all types of local growths so far as the cervix are concerned do not lend themselves equally well to exactly the same technique of radium treatment and a strong plea is made for individualization of the radium planning so that the best possible distribution of radium is used for a particular type of growth being treated.
It has long been recognized that certain tynes of growth whatever their situation in the body, respond better than others to radio-therapy, even though they may be situated in exactly the, same part.
The soft proliferating mass is highly radio-sensitive whatever its histology. This kind of growth has an excellent blood supply, which is a great advantage in radio-therapy.
The hard infiltrating well-differentiated growth, extending deeply but slowly into the tissues in order to obtain enough blood supply to grow, is the least radiosensitive. There is a third type of carcinoma which'grows rapidly-14ndZ&MVastic. On account of its satisfactory blood supply it may foi i;g ii lajg9 r ulperating mass, or only partially ulcerated mass, near the os, and r7'?mt?Wtd1a2Rp aC mass in one or both broad ligaments. It is very radio-sensitive.
In the Royal Northern Hospital, Radiotherapy Department, the above principles guide the plan of treatment. Anything but a small growth receives preliminary X-ray therapy especially if it is not highly differentiated.
A proliferating mass is treated by a ring of radium in a rubber ring pessary-like container fixed mechanically to an intra-uterine tube. The growth fits into the ring and is evenly dosed.
An eroding cavity or stenosed vault is treated by a sphere fitting up in the vault and attached mechanically to an intra-uterine tube on a stem which passes through the sphere, A large vault is utilized to take a large egg-shaped applicator comparable in size to Drs. Donaldson and Neary's model. I intend to use their principle of screening from now on.
Mr. Rees of the Gynecological Department agrees with me that individualization has improved the results.
A new method of treating a mass in the broad ligament by rotation X-ray therapy focusing the X-rays accurately and offering more hope for these advanced cases is now being used at the hospital.
Mr. G. W. Blomfield: The Sheffield appliance for carcinoma of the cervix is for a single vaginal source of radium placed in the central axis. It is, perhaps, less effective in the cut off of radiation to the point generally known as "point A" but it is. possibly more versatile and adaptable. It is used in conjunction with a separate uterine source and "spacers" of different sizes are used for packing the vaginal walls away from the appliance. This appliance has a spherical head of platinum giving 1 cm. screenage over the rectum reducing the dose in this direction to 25%. The main beams are directed upwards and forwards at angles which have been worked out after making a number of dissections on autopsies, the aim being to give maximal radiation to the parametrium and pelvic wall whilst not taking the rectum, bladder or pouch of Douglas above tolerance. A second applicator is now under construction, having a detachable cap which can be removed when there is difficulty in applying intra-uterine radium. This will then direct extra radiation upwards at an angle which can be adjusted to suit requirements. The vaginal radium is inserted after all else has been fixed to the satisfaction of the operator and can be removed without disturbing the appliance.
In answer to questions.-I do not think that the difficulty encountered in cases of stenosed vagina is of great moment. Those cases with advanced stenosing growth will not be cured by any technique we know of at present, whatever the type may be histologically. They require a modified technique.
The amount of radium used in the Sheffield appliance is 200 mg. of pure radium in a. tube of active size 7 mm. length by 4-4 mm. diameter. The uterine source is 30 or 40 mg. total, in a separate uterine tube. The time of application is varied according to the size of the spacers used.
Previous trials, completed a year ago, with a lead appliance and two radon sources, have shown that the technique of using heavily screened radium in the central vaginal axis works clinically and makes increased dosage possible without danger, but the screenage must give adequate cut off of radiation in the correct anatomical directions. [Jutne 15, 1945] Congenital Defects Following Rubella in Pregnancy.-IVOR HUGHES, F.R.C.S.
This case manifests most of the congenital lesions which have been stated by Gregg [1I, Swan [2] , Erickson [31 and other writers to occur when an expectant mother contracts rubella in the early months of pregnancy.
Mrs. E. contracted this disease in the second month of her first pregnancy, the infection being of a mild tvpe. Her brother-in-law, who is a doctor, diagnosed the disease as rubella and insisted on her remaining in bed for three davs although she stated that she felt well enough to carry on with normal duties. I stress this point because it has been suggested that the virulence of the unknown virus of rubella has possibly been enhanced in the war years, so producing lesions which have not been recognized earlier.
The babv was born two weeks after term (date of birth 21.11.40) and, like other cases quoted, he was small, ill-nourished and difficult to feed, pale, irritable and a poor sleeper. Weight at birth 6 lb. 6 oz. Later a congenital cataract of the left eye was noted with enophthalmos. Nystagmus was demonstrated at a later date. This tvpe of cataract bears no resemblance to anv other type of congenital lesion of the eye described by Duke-Elder [6] . Mason in 1937, Parsons in 1936 and others. Some observers note that a bilateral cataract is more common than a unilateral lesion.
Deafness was noticed as the child grew older and now deaf-mutism plus mental retardation areobvious.
He has the typical congenital heart lesion, due to a patent foramen ovale in the interventricular septum.
At present he is smaller and lighter in weight than the average child, and, in comparison with his brother, who is two years vounger, appears t-o have microcephalv.
